Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Lantheus Holdings, Inc. | Chief Medical Officer | Common Stock | 38.8K | $2.54M | $65.36 | Mar 5, 2024 | By Theranostics Consulting SAS |
Lantheus Holdings, Inc. | Chief Medical Officer | Stock Option (right to buy) | 11K | Mar 1, 2024 | By Theranostics Consulting SAS |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LNTH | Lantheus Holdings, Inc. | Mar 5, 2024 | 1 | -$35.7K | 4 | Mar 7, 2024 | Chief Medical Officer |
LNTH | Lantheus Holdings, Inc. | Mar 1, 2024 | 2 | $0 | 4 | Mar 5, 2024 | Chief Medical Officer |
LNTH | Lantheus Holdings, Inc. | Mar 2, 2023 | 2 | $0 | 4 | Mar 6, 2023 | Chief Medical Officer |
LNTH | Lantheus Holdings, Inc. | Jan 1, 2023 | 0 | $0 | 3 | Jan 10, 2023 | Chief Medical Officer |